Literature DB >> 9266670

Expression vectors for the introduction of highly diverged sequences into the six complementarity-determining regions of an antibody.

Y Iba1, W Ito, Y Kurosawa.   

Abstract

We prepared three kinds of phagemid vector that permit the simultaneous introduction of highly diverged sequences into six complementarity-determining regions (CDRs) of an antibody (Ab) by the polymerase chain reaction (PCR) with degenerate oligodeoxynucleotide (oligo) primers. The phages expressed either the Fv, single-chain Fv (sc Fv) or Fab form of an Ab fused with a half-molecule of cpIII on the surface of M13 phage. A phage-display library, composed of 2 x 10(8) independent clones, was constructed; the phages that were specific for hen egg-white lysozyme (HEL) were selected by three rounds of panning; and 20 clones were isolated. The isolated clones consisted of 17 different clones. Among them, 16 clones expressed proteins that were able to bind to HEL. The association constants for binding of the encoded proteins to HEL ranged from 1.48 x 10(6) to 7.71 x 10(6)/M. These vectors allowed us to prepare many libraries of artificial Ab in which the sequences of six CDRs were very different and reflected the artificial sequences that had been designed for the degenerate oligo that we used as primers for PCR. The libraries should be also useful for the analysis of relationships between the sequences of the CDRs and antigen (Ag) specificity.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9266670     DOI: 10.1016/s0378-1119(97)00101-7

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  8 in total

1.  Isolation of human monoclonal antibodies that neutralize human rotavirus.

Authors:  Kyoko Higo-Moriguchi; Yasushi Akahori; Yoshitaka Iba; Yoshikazu Kurosawa; Koki Taniguchi
Journal:  J Virol       Date:  2004-04       Impact factor: 5.103

2.  An engineered chaperonin caging a guest protein: Structural insights and potential as a protein expression tool.

Authors:  Masahiro Furutani; Jun-Ichi Hata; Yasuhito Shomura; Keisuke Itami; Takao Yoshida; Yoshitaka Izumoto; Akiko Togi; Akira Ideno; Takuo Yasunaga; Kunio Miki; Tadashi Maruyama
Journal:  Protein Sci       Date:  2005-02       Impact factor: 6.725

3.  Isolation of a human monoclonal antibody with strong neutralizing activity against diphtheria toxin.

Authors:  Mai Kakita; Tsuyoshi Takahashi; Takako Komiya; Yoshitaka Iba; Takao Tsuji; Yoshikazu Kurosawa; Motohide Takahashi
Journal:  Infect Immun       Date:  2006-06       Impact factor: 3.441

4.  FK506 binding protein from the hyperthermophilic archaeon Pyrococcus horikoshii suppresses the aggregation of proteins in Escherichia coli.

Authors:  Akira Ideno; Masahiro Furutani; Yoshitaka Iba; Yoshikazu Kurosawa; Tadashi Maruyama
Journal:  Appl Environ Microbiol       Date:  2002-02       Impact factor: 4.792

5.  Naturally occurring antibodies in humans can neutralize a variety of influenza virus strains, including H3, H1, H2, and H5.

Authors:  Nobuko Ohshima; Yoshitaka Iba; Ritsuko Kubota-Koketsu; Yoshizo Asano; Yoshinobu Okuno; Yoshikazu Kurosawa
Journal:  J Virol       Date:  2011-08-24       Impact factor: 5.103

6.  Conserved neutralizing epitope at globular head of hemagglutinin in H3N2 influenza viruses.

Authors:  Yoshitaka Iba; Yoshifumi Fujii; Nobuko Ohshima; Tomomi Sumida; Ritsuko Kubota-Koketsu; Mariko Ikeda; Motoaki Wakiyama; Mikako Shirouzu; Jun Okada; Yoshinobu Okuno; Yoshikazu Kurosawa; Shigeyuki Yokoyama
Journal:  J Virol       Date:  2014-04-09       Impact factor: 5.103

7.  Two types of antibodies are induced by vaccination with A/California/2009 pdm virus: binding near the sialic acid-binding pocket and neutralizing both H1N1 and H5N1 viruses.

Authors:  Nobuko Ohshima; Ritsuko Kubota-Koketsu; Yoshitaka Iba; Yoshinobu Okuno; Yoshikazu Kurosawa
Journal:  PLoS One       Date:  2014-02-05       Impact factor: 3.240

8.  Comprehensive Analysis of Antibodies Induced by Vaccination with 4 Kinds of Avian Influenza H5N1 Pre-Pandemic Vaccines.

Authors:  Nobuko Ohshima; Yoshitaka Iba; Ritsuko Kubota-Koketsu; Ayami Yamasaki; Keiko Majima; Gene Kurosawa; Daisuke Hirano; Shunji Yoshida; Mototaka Sugiura; Yoshizo Asano; Yoshinobu Okuno; Yoshikazu Kurosawa
Journal:  Int J Mol Sci       Date:  2020-10-08       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.